The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate

Bobardt, M; Kuo, J; Chatterji, U; Chanda, S; Little, SJ; Wiedemann, N; Vuagniaux, G; Gallay, PA

Gallay, PA (reprint author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.

PLOS ONE, 2019; 14 (2):

Abstract

Antiretroviral therapy (ART) suppresses HIV replication, but does not cure the infection because replication-competent virus persists within latently ......

Full Text Link